Stock Ratings / Health Care / UNH / forecast

LLY (72) JNJ (66) ABBV (71) MRK (66) ⌘ Pro Terminal →

UnitedHealth Group Incorporated (UNH) 12-Month Stock Forecast & Price Target Cone

$410.91 +0.94% NYSE • Public Delayed / 60s Snapshot

UnitedHealth Group Incorporated (UNH) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $364.66B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw B- · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+19.2% Base Target

WHALE OPTIONS TUG-OF-WAR:27% Call Buyers ($874.0K)

73% PutsMax Pain: $400.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your UNH Position Size: $10,000

Shares at $410.91: 24.3 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $431.19

$10,494

+$494 (+4.9%)

12M Consensus BaseTarget $489.88

$11,922

+$1,922 (+19.2%)

12M Bull Case BreakoutTarget $531.31

$12,930

+$2,930 (+29.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (33 Desks)

Street Historical Accuracy: 73/100

● Strong Buy / Buy: 26● Hold: 7● Sell: 0

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
JefferiesAkash Tewari	STRONG BUY	$487	96%	A+
BarclaysCarter Gould / Andrew Mok	BUY	$431	96%	A+
UBSAJ Rice	OUTPERFORM	$464	76.5%	B
Morgan StanleyTerence Flynn	STRONG BUY	$504	70.3%	B
CitigroupPeter Verdult	STRONG BUY	$486	70%	B
Bernstein SocGen GroupCourtney Breen / Lance Wilkes	OUTPERFORM	$472	65.4%	C
Bank of America SecuritiesTim Anderson / Kevin Fischbeck	STRONG BUY	$531	65.2%	C
Goldman SachsChris Shibutani	STRONG BUY	$516	64.2%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Senior Cash-Flow & Income Strategist

Cash-Fortress Compounders: Collecting Safe Yield & Upside in UNH & Top A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on UNH and its top sector rival
✓The Top 5 Roarable A-Rated cash compounders with heavy executive & 13F accumulation
✓Includes free daily Morning Market Weather & signal upgrade/downgrade dispatch

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

UNH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +10.36%⚡ TESTING RESISTANCE

2026-10-30O $419.0H $420.9L $404.3C $407.0VOL 20.32M

RES: $407.5SUP: $348.4SMA50: $390.2SMA200: $362.8

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UNH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UNH Butterfly Map → + Track UNH →

Share Count & Dilution Monitor (#25)

-1.94% YoY Shares

SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.

Reverse-DCF Expectations Hurdle (#30)

19.5%/yr Implied 5Y Growth

vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UNH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

LLY → UNH Confirmed Filing

FDA label expansions of GLP-1 drugs into cardiovascular risk reduction, obstructive sleep apnea, and kidney disease unlock Medicare Part D statutory coverage, elevating UnitedHealthcare specialty drug costs.

AI Analyst Theses, Washington Policy & Company Video 🏛️ COMMENT_RULEMAKING: CMS Contract Year Medicare Advantage Capitation Benchmark & Part D GLP-1 Coverage Rulemaking (Centers for Medicare & Medicaid Services (HHS — 42 CFR Parts 422 & 423))

🎬 No recent verified company-specific video clip queued for UNH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

UNH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is UNH's 12-month stock price target?

UnitedHealth Group Incorporated (UNH) carries a 12-month consensus base price target of $489.88 (+19.2% from $410.91), with a bull-case target of $531.31 and a bear-case floor of $431.19.